Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...

GLP-1 receptor agonist therapy for type 2 diabetes or obesity is associated with a significantly lower risk of developing colon cancer.

While there are several treatment options for colon cancer, not all of them work for all cancer types. Deficient mismatch repair (dMMR) colon cancer is known to be less responsive to chemotherapy than ...

Colon cancers are especially tough to treat in their advanced stages A new trial finds the use of two immunotherapy drugs plus standard chemo nearly doubled survival times in patients with these ...

Colorectal cancer often spreads to the liver, requiring prolonged chemotherapy. But now, doctors are turning to hepatic artery infusion. This therapy delivers chemo directly into the liver, and that, ...

Younger colorectal cancer patients have abnormally stiff colon tissue that promotes tumor growth, pointing to biomechanical ...

People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds. A combination of two experimental immunotherapy drugs plus standard ...

Please provide your email address to receive an email when new articles are posted on . Patients with stage III or high-risk stage II colon cancer in a structured exercise program had 28% lower risk ...

Better out than in, they say? At least that seems to be the general consensus amongst the who’s who of the wellness community—where colonics seem to be all the rage. If you’re not familiar with the ...

WASHINGTON (Reuters) - Hormone replacement therapy may raise a woman's risk of breast cancer and heart disease but it lowers her risk of colon cancer, according to two studies released on Wednesday.

Suicide gene therapy consists of introduction into tumor cells of a non-mammalian gene encoding an enzyme (such as cytosine deaminase) that converts a non-toxic prodrug (5-fluorocytosine) into a ...